A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection
Authors:
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 49 (8) , 607-615
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis BHepatitis Monthly, 2014
- Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virusAlimentary Pharmacology & Therapeutics, 2013
- Comparison of FIB‐4 and APRI in Chinese HBV‐infected patients with persistently normal ALT and mildly elevated ALTJournal of Viral Hepatitis, 2012
- Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral LoadPLOS ONE, 2011
- Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis BClinica Chimica Acta, 2011
- Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patientsLiver International, 2010
- Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative studyWorld Journal of Gastroenterology, 2010
- The accuracy of the FIB‐4 index for the diagnosis of mild fibrosis in chronic hepatitis BAlimentary Pharmacology & Therapeutics, 2009
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesNew England Journal of Medicine, 2004
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995